Phase 1: Discovery and Development

• Discovering novel translational research findings from biomedical data by generative AI-enabled medical technology
• Developing AI technology for elucidating molecular disease mechanisms and real-world quantification of related clinical decision making

Phase 2: Credentialing and Translation

• Deploying and credentialing of AI models for enabling diagnostic tests, their replicability, and proof of their clinical utility
• Clinical translation of AI-enabled personalized diagnostics and therapeutics by software as a medical device digital trials
• Empowering patients, physicians, researchers, and regulators for making informed and equitable healthcare decisions